Cutaneous leukocytoclastic angiitis
MONDO:0019509Cutaneous leukocytoclastic angiitis is a small-vessel vasculitis presenting with palpable purpura and urticarial lesions which predate the purpuric lesions most frequently observed on the legs. Systemic symptoms including fever, cough, hemoptysis, sinusitis, arthralgia, arthritis, myalgia, abdominal pain, diarrhea, hematochezia, paresthesia, weakness, and hematuria may be observed. Skin biopsy reveals exudates rich in neutrophils, endothelial damage, fibrin deposition, and leukocytoclasis in postcapillary venules of small vessels. Cutaneous leukocytoclastic angiitis can be idiopathic (in up to 50% of cases) or secondary to infections, medications (such as antituberculosis medication), collagen vascular diseases, or neoplasms.
Also known as: cutaneous hypersensitivity vasculitis, cutaneous leukocytoclastic vasculitis, cutaneous small vessel vasculitis, cutaneous small-vessel vasculitis, hypersensitivity angiitis, leukocytoclastic angiitis
3 clinical trials for this condition and its sub-types, 1 tagged with Cutaneous leukocytoclastic angiitis itself.
Follow this condition to get notified about new trialsWhere it sits in the disease tree
Browse by category →-
Which drug tames skin vasculitis best? new trial aims to find out
Disease control Recruiting nowThis study tests three standard medications—colchicine, dapsone, and azathioprine—in 90 people with isolated skin vasculitis (inflammation of small or medium blood vessels in the skin). Participants are randomly assigned to one of the drugs, and doctors track how well the skin re…
Phase 2 • Sponsor: University of Pennsylvania • Aim: Disease control
Last updated Aug 22, 2026 00:00 UTC
-
Vasculitis patients wanted for major 5-Year observation study
Knowledge-focused Recruiting nowThis study is following 670 adults with vasculitis, a rare blood vessel disease, for up to 5 years. Researchers will collect medical data and blood samples to see how the disease starts, how it is treated, and what long-term problems may arise. No new treatments are being tested—…
Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Knowledge-focused
Last updated Jun 26, 2026 15:31 UTC